News and Announcements
GasHub Signs MOU with Sinochem
- Published August 15, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
GasHub, focused on gas-piping and energy services has released information in regards to the company to be listed on the Australian Securities Exchange (ASX) in the next few months.
KEY TAKEAWAYS:
- Signed Memorandum of Understanding (MOUs) with Sitra Holdings (International) and AbsoEnergy.
- AbsoEnergy is the Asia-Pacific representative of Chinese state-owned enterprise Shanghai Sinochen JN Energy Co Ltd.
- AbsoEnergy, Managing Director, Kelvin Sim said that representing Sinochem in the Asia-Pacific region meant that all agreements and joint ventures with Sinochem will be signed by AbsoEnergy.
- GasHub’s MOU with Sitra establishes the joint intention of both companies to work towards.
- The MOU has also established the intent for Sitra and GasHub to jointly market the 3GEX CHP.
- Since GasHub’s system works off natural gas, this MOU will allow the company to market their product to more customers in remote locations.
GasHub sais “using a CHP system would result in cost savings of about 25 per cent compared with running regular heating and power systems”.
GasHub CEO Aviers Lim said: “These MOUs demonstrate a greater demand for cleaner energy in the region, as well as growing interest in our patented technology solutions which help businesses save on energy costs with a more sustainable natural gas supply. We are pleased with this good momentum in the lead-up to our upcoming listing on the ASX, and look forward to more of such collaborations in the pipeline.”
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
